Wednesday, September 23, 2026

Avista Corporation And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Avista Corporation And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. Avista Corporation

8.6% sales growth and 6.53% return on equity

Avista Corporation operates as an electric and natural gas utility company.

Avista Corporation's sales growth this year is expected to be 9.4% and 4.7% for next year.

Year-on-year quarterly revenue growth grew by 4.4%, now sitting on 1.32B for the twelve trailing months.

Avista Corporation's sales growth for the next quarter is 8.6%. The company's growth estimates for the current quarter and the next is 13.9% and 3.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.53%.

Volatility

Avista Corporation's last day, last week, and last month's current volatility was 0.02%, 0.30%, and 1.32%, respectively.

Avista Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.12% (day), 1.91% (last week), and 2.62% (last month), respectively.

Avista Corporation's Stock Yearly Top and Bottom Value

Avista Corporation's stock is valued at $47.57 at 08:22 EST, below its 52-week high of $49.14 and way higher than its 52-week low of $32.26.

Avista Corporation's Moving Average

Avista Corporation's worth is higher than its 50-day moving average of $43.26 and way above its 200-day moving average of $38.63.

3. Calix, Inc

15.7% sales growth and 15.42% return on equity

Calix, Inc., together with its subsidiaries, provides cloud and software platforms, and systems and services required to deliver the unified access network in the United States, the Middle East, Canada, Europe, the Caribbean, and internationally.

Calix, Inc's sales growth this year is anticipated to be 10.7% and 12% for next year.

Year-on-year quarterly revenue growth grew by 41.5%, now sitting on 541.24M for the twelve trailing months.

Calix, Inc's sales growth for the next quarter is 15.7%. The company's growth estimates for the ongoing quarter and the next is 575% and 14.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.42%.

Volatility

Calix, Inc's last day, last week, and last month's current volatility was 2.42%, 2.60%, and 4.05%, respectively.

Calix, Inc's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.03% (day), 5.72% (last week), and 6.73% (last month), respectively.

Calix, Inc's Stock Yearly Top and Bottom Value

Calix, Inc's stock is valued at $41.45 at 08:22 EST, way below its 52-week high of $48.78 and way higher than its 52-week low of $6.90.

Calix, Inc's Moving Average

Calix, Inc's worth is above its 50-day moving average of $40.72 and way higher than its 200-day moving average of $30.59.

4. Viomi Technology Co., Ltd

31.4% sales growth and 12.01% return on equity

Viomi Technology Co., Ltd, through its subsidiaries, develops and sells Internet-of-things-enabled (IoT-enabled) smart home products in the People's Republic of China.

Viomi Technology Co., Ltd's sales growth this year is anticipated to be 21.5% and 8.6% for next year.

Year-on-year quarterly revenue growth grew by 8.5%, now sitting on 5.83B for the twelve trailing months.

Viomi Technology Co., Ltd's sales growth for the next quarter is 31.4%. The company's growth estimates for the present quarter and the next is 100% and 87.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.01%.

Volatility

Viomi Technology Co., Ltd's last day, last week, and last month's current volatility was 0.31%, 1.17%, and 5.18%, respectively.

Viomi Technology Co., Ltd's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 6.19% (day), 6.79% (last week), and 11.14% (last month), respectively.

Viomi Technology Co., Ltd's Stock Yearly Top and Bottom Value

Viomi Technology Co., Ltd's stock is valued at $9.61 at 08:22 EST, way below its 52-week high of $18.99 and way above its 52-week low of $4.84.

Viomi Technology Co., Ltd's Moving Average

Viomi Technology Co., Ltd's worth is way under its 50-day moving average of $11.24 and way higher than its 200-day moving average of $7.58.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com